Fred Hutch study: Mangling RNA may extend use of immunotherapy drugs
Fred Hutch computer biologist Robert Bradley. (Fred Hutch photo) Experimental compounds that alter RNA increase the effectiveness of immunotherapeutic drugs against cancer cells and could potentially extend their use to more patients, suggests a study in mice at the Fred Hutchinson Cancer Research Center. Immunotherapeutic agents called checkpoint inhibitors, which induce the immune system to … Read more
